Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea (NCT02630121)
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea. A Double Blinded Placebo Controlled, Crossover Prospective Trial.
🩺 Plain-English Summary (8th-Grade Level)
The addition of intranasal oxymetazoline for two weeks to already instituted optimal doses of intranasal fluticasone propionate will decrease the total number of obstructive apneas and hypopneas per hour of sleep in subjects with perennial allergic or non-allergic rhinitis and mild obstructive sleep apnea who have persistent nasal congestion despite maximum doses of NGCS.
Who can join: Review the eligibility criteria below.
Location: Usf Asthma Allergy and Immunology Cru — Tampa, Florida
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Usf Asthma Allergy and Immunology Cru — Tampa, Florida
📞 Contact the Study Coordinator
Phone: (813) 631-4024
Email: catherinesmith@health.usf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Sleep Apnea
- Mechanisms of Prediabetic States in Sleep Apnea — Chicago, Illinois
- Technology-Supported Treatment of Sleep Apnea in Prediabetes — Chicago, Illinois
- Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea — La Jolla, California
- Behavioral Optimization to Overcome Obstructive Sleep Apnea Treatment Barriers — West Los Angeles, California
- Janus II Feasibility — Scottsdale, Arizona
- Sleep Disordered Breathing With Opioid Use — Detroit, Michigan
Explore by condition: All Sleep Apnea clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.